Pathogenic variants of the SPINK1 and PRSS1 genes have the maximum impact on the risk of CP development in patients from different countries, as the products of these genes are key participants in the trypsin-dependent pathogenetic pathway of the pancreatitis development. The gene discussed is SPINK1; the disease is pancreatitis.